Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boyd

Showing results (1191-1200 of 1,528) with videos related to

Pageof 153
Sort By:
Drug Delivery and Translational Research|July 29, 2016
Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic feverRosemary Wyber, Ben J Boyd, Samantha Colquhoun, et al.
Genomics|May 16, 2001
Genomic organization of the CC chemokine mip-3alpha/CCL20/larc/exodus/SCYA20, showing gene structure, splice variants, and chromosome localizationR T Nelson, J Boyd, R P Gladue, et al.
British Journal of Haematology|June 1, 1997
Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDFJ E Rasko, R L Basser, J Boyd, et al.
BMJ Quality & Safety|November 17, 2019
'New Medicine Service': supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trialRachel Ann Elliott, Matthew J Boyd, Lukasz Tanajewski, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 29, 2019
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systemsBen J Boyd, Christel A S Bergström, Zahari Vinarov, et al.
BMJ Quality & Safety|December 10, 2015
Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine ServiceRachel Ann Elliott, Matthew J Boyd, Nde-Eshimuni Salema, et al.
The New England Journal of Medicine|November 7, 1996
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1S C Rubin, I Benjamin, K Behbakht, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|March 12, 2014
Prevention trial in the Cherokee Nation: design of a randomized community trialKelli A Komro, Alexander C Wagenaar, Misty Boyd, et al.
The Journal of Biological Chemistry|April 11, 2020
The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of actionWayne Mitchell, Emily A Ng, Jeffrey D Tamucci, et al.
British Journal of Cancer|April 18, 2007
Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locusV A L Tomlinson, H J Newbery, J H Bergmann, et al.
Pageof 153

Showing results (1191-1200 of 1,528) with videos related to

Sort By:
Pageof 153
Drug Delivery and Translational Research|July 29, 2016
Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic feverRosemary Wyber, Ben J Boyd, Samantha Colquhoun, et al.
Genomics|May 16, 2001
Genomic organization of the CC chemokine mip-3alpha/CCL20/larc/exodus/SCYA20, showing gene structure, splice variants, and chromosome localizationR T Nelson, J Boyd, R P Gladue, et al.
British Journal of Haematology|June 1, 1997
Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDFJ E Rasko, R L Basser, J Boyd, et al.
BMJ Quality & Safety|November 17, 2019
'New Medicine Service': supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trialRachel Ann Elliott, Matthew J Boyd, Lukasz Tanajewski, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 29, 2019
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systemsBen J Boyd, Christel A S Bergström, Zahari Vinarov, et al.
BMJ Quality & Safety|December 10, 2015
Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine ServiceRachel Ann Elliott, Matthew J Boyd, Nde-Eshimuni Salema, et al.
The New England Journal of Medicine|November 7, 1996
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1S C Rubin, I Benjamin, K Behbakht, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|March 12, 2014
Prevention trial in the Cherokee Nation: design of a randomized community trialKelli A Komro, Alexander C Wagenaar, Misty Boyd, et al.
The Journal of Biological Chemistry|April 11, 2020
The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of actionWayne Mitchell, Emily A Ng, Jeffrey D Tamucci, et al.
British Journal of Cancer|April 18, 2007
Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locusV A L Tomlinson, H J Newbery, J H Bergmann, et al.
Pageof 153